What one share of AngioDynamics holds
AngioDynamics is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing and selling products and technologies which aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses.
AngioDynamics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-08-31; the balance sheet is as of 2026-08-31.
| Sales | $7.80 |
|---|---|
| Profit | −$0.79 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | $0.03 |
| Cash and investments | $0.80 |
| Book value | $3.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $8.72 | $0.50 | $0.20 | $1.41 | — | $15.92 |
| 2011 | $8.58 | $0.32 | $0.12 | $1.23 | — | $16.23 |
| 2012 | $8.74 | −$0.20 | $0.10 | $0.36 | — | $15.03 |
| 2013 | $9.82 | −$0.03 | $0.35 | $0.42 | — | $15.01 |
| 2014 | $10.00 | $0.07 | $0.32 | $0.38 | — | $15.15 |
| 2015 | $9.99 | −$0.09 | $0.32 | $0.40 | — | $15.18 |
| 2016 | $9.79 | −$1.21 | $0.06 | $1.19 | — | $13.98 |
| 2017 | $7.37 | $0.14 | $0.08 | $1.44 | — | $13.98 |
| 2018 | $7.06 | $0.44 | $0.06 | $1.05 | — | $14.58 |
| 2019 | $7.22 | $1.64 | $0.08 | $0.92 | — | $16.35 |
| 2020 | $6.96 | −$4.39 | $0.19 | −$0.57 | — | $11.95 |
| 2021 | $7.59 | −$0.82 | $0.14 | $0.49 | — | $11.40 |
| 2022 | $8.11 | −$0.68 | $0.11 | −$0.29 | — | $10.84 |
| 2023 | $8.58 | −$1.33 | $0.10 | −$0.09 | — | $9.55 |
| 2024 | $7.56 | −$4.59 | $0.06 | −$0.76 | — | $5.08 |
| 2025 | $7.16 | −$0.83 | $0.11 | −$0.36 | — | $4.46 |
| 2026 | $7.71 | −$0.88 | $0.06 | $0.01 | — | $4.10 |
Common questions about AngioDynamics
How much does one share of AngioDynamics earn?
Over the last 12 months, AngioDynamics lost $0.79 for each share on $7.80 of sales.
Does AngioDynamics pay a dividend?
AngioDynamics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is AngioDynamics’s book value per share?
AngioDynamics’s book value is $3.86 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of August 31, 2026.
How much cash and debt does each share of AngioDynamics have?
Each share of AngioDynamics has $0.80 of cash and investments, as of August 31, 2026.
What is AngioDynamics’s free cash flow per share?
$0.03 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has AngioDynamics bought back shares?
AngioDynamics’s share count rose about 68% from 2010 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.